Covid-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and
pick up market share from much larger rivals, Pfizer and Moderna.
The company posted a larger-than-expected fourth-quarter loss as revenue lagged analysts' estimates.
Chief executive John Jacobs said Novavax claimed just a low-single-digit percentage market share in the US during the most recent vaccination campaign, as demand
for Covid vaccines was smaller than hoped and the company got its protein-based shot to market later than its messenger RNA-based rivals.
"We were disappointed with that US performance," Jacobs said in an interview.
He said the company's sales force was not targeted enough toward retail pharmacy chains, and that its 5-dose vials were not as convenient for use as rivals'
pre-filled syringes.
The Royal Pharmaceutical Society (RPS) and the Pharmacists' Defence Association (PDA) have responded to the Department of Health and Social Care (DHSC)
consultation on pharmacy supervision, which was launched in early December last year.
The DSHC set out proposals to amend the Medicines Act 1968 and The Human Medicines Regulations 2012 to allow registered pharmacy technicians to work without
direct supervision, which in turn will help free up pharmacists to provide more clinical care and reduce GP appointments.
While the RPS supported the legislative change, it highlighted a range of topics that should be considered and clarified in regulations and guidance.
According to RPS, the new concept of 'authorisation', including around documentation, accountability, and the role of superintendent pharmacist and responsible
pharmacist, needs clarification.
A Labour Party analysis of NHS trust figures has revealed that around 148,000 people died last year while waiting for treatment in England.
This is more than double the figure recorded in 2017/18, which stood at around 60,000 deaths. It even surpasses the mortality rate observed in 2021, during
the peak of the Covid pandemic.
The Labour Party obtained the data through a freedom of information request sent to every NHS trust in England. Out of the 169 acute and community trusts
contacted, 80 responded.
The total number of deaths reported by the respondents was 61,396. Extrapolating this figure to all trusts would suggest a total of 148,227 deaths.
In his first speech as Secretary of State for Health and Social Care, Wes Streeting MP acknowledged that the NHS is in crisis while outlining his mission to
save the health service.
Streeting described the current state of the NHS as "broken," noting its failure to meet the needs of both patients and dedicated healthcare professionals.
"When we said during the election campaign, that the NHS was going through the biggest crisis in its history, we meant it.
"When we said that patients are being failed on a daily basis, it wasn't political rhetoric, but the daily reality faced by millions," he said on Friday (5 July).
The new health secretary remarked that previous governments had been unwilling to admit these simple facts.
To combat the effects of climate change, the Integrated Care System (ICS) in South East London (SEL) has initiated a pioneering inhaler recycling project.
Supported by NHS England and spanning 20 community pharmacies across the region, the project marks the first nationally-funded pilot of its kind in England,
targeting the reduction of greenhouse gas emissions from improperly disposed inhalers.
The project, which commenced at King's College Hospital in February 2024, focuses on the recycling of pressurised metered-dose inhalers.
These inhalers, due to their propellant content, contribute significantly to environmental harm, emitting gases equivalent to driving 71.8 miles in a standard
petrol car.